BRMS1 and breast cancer: Recent studies have indicated that BRMS1 expression was reduced in breast cancer, melanoma, ovarian cancer, nasopharyngeal carcinoma and non-small cell lung cancer (NSCLC), and seemed to be associated with cancer cell invasion, metastasis and patients' prognosis [6]–[12].